Corneal Collagen Cross-linking (CXL) as an adjunct in the treatment of Microbial Keratitis

Microbial keratitis is a serious eye infection of the cornea (the clear front surface of the eye) that can cause significant vision loss if not treated quickly. This study is testing whether adding ultraviolet light treatment (corneal collagen cross-linking, or CXL) — which is known to kill bacteria and fungi — alongside standard antibiotic treatment speeds up recovery and leads to better vision outcomes for people with moderate to severe corneal infections. You may be eligible if: - You have a presumed or confirmed moderate-to-severe microbial infection of the cornea (microbial keratitis) You may NOT be eligible if: - You are pregnant - Your cornea is at risk of perforating (developing a hole) or has already perforated Talk to your doctor about whether this trial might be right for you.